Anna Kazanchyan, M.D. has more than 25 years of experience as a senior executive in the biopharmaceutical and healthcare finance industries, including marquee Wall Street firms, and as an entrepreneur. She has a unique combination of clinical medicine, equity research, business/clinical/regulatory strategy as well as business development experience and expertise. Dr. Kazanchyan has served as a member of the Board of Directors and the Compensation Committee for publicly-traded biopharma companies and also serves as a Coach for the WomenInBio’s BoardRoom Ready initiative.

Dr. Kazanchyan is the Founder & CEO of Saghmos Therapeutics. Prior to this, she was SVP, Business Development and SVP, Product Development at Ovid Therapeutics. Dr. Kazanchyan was Founder and Managing Partner of Primary i-Research, where she was a strategic advisor to CEOs of biopharmaceutical companies on business development, regulatory strategy, marketing, and commercial/competitive landscape, as well as equity/debt financing. She has also provided due diligence to leading healthcare investment funds and evaluated investment prospects of biopharmaceutical companies based on the scientific, clinical, regulatory and commercial outlook for their products. Previously, Dr. Kazanchyan was Senior Biotechnology Analyst at Wells Fargo, and was a member of the Institutional-Investor ranked Biotechnology Equity Research teams at Goldman Sachs and Citi. She received an M.D. from Harvard Medical School.